SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Viking Ozone Technology obtained a formal French Attestation of Conformity for its VKIN-300 ozone-based system on October 28, 2026, validating its compliance with NF X 30-503-1:202…
OppFi withdrew its regulatory applications for the acquisition of BNC National Bank due to a lack of clear standards, reaffirming its 2026 financial guidance despite the regulatory…
SeaStar Medical announced FDA approval to expand post-approval study requirements for its pediatric sepsis-associated AKI device, following a registry study that showed improved su…
Compass Pathways plans to file its NDA in two weeks and targets H1 2027 launch. The company reported strong third quarter financials, reinforcing its progress toward a potential bl…
Mercer International amended its Senior Notes Indenture, changing the grace period for default from 30 to 90 days, effective upon execution.
Spire Missouri filed a rate case with the PSC to fund natural gas system upgrades, potentially increasing residential bills by approximately $10 to $13 per month starting next fall…
Nu-Med Plus, Inc. adopted a bylaw amendment, effective immediately, to specify that a majority of voting shares is required to transfer the company's domicile to another jurisdicti…
The company filed an Amended and Restated Certificate of Incorporation, increasing authorized capital stock to 510 million shares and changing the corporation's name from Aspen Bio…
Destination XL Group set its 2026 annual meeting for Dec. 17 and established new proxy proposal deadlines of Nov. 12, removing older requirements from the 2025 meeting. The event w…
Select Water Solutions' guaranteeing subsidiaries executed an amendment to the company's indenture, unconditionally guaranteeing the company's 7.625% Senior Notes due 2034, a move …
Davey Tree Expert Company has entered into a Fourth Amendment to its Credit Agreement with several banks, including KeyBank National Association, as of October 29, 2026.
FDA issues final guidance to manufacturers of cellular and gene therapy products regarding science- and risk-based plans to meet potency standards.
The company filed a restated certificate of incorporation with the SEC, which includes provisions to limit the liability of directors and officers and to indemnify them against cer…
CBIZ, Inc. filed an updated certificate of incorporation, including a change to authorized capital stock and amendments to fiduciary liability and director activities.
Kimberly-Clark has filed an exhibit containing its Bylaws, updated through November 2, 2026. This filing signals an update to corporate governance regulations filed with the SEC.
NRx received FDA approval for its preservative-free ketamine andase Raywood deal
Lightbridge announced selection for the DOE Nuclear Energy Launch Pad at INL to build a pilot fuel factory and reported Q3 2026 financial results. The news suggests a significant a…
uniQure announced FDA acceptance of the ifezuntirgene inilparvovec Biologics License Application with a Priority Review designation and a PDUFA target date of May 1, 2027. The news…
INOVIO Pharmaceuticals has been granted accelerated FDA approval for VOCERYQ, an immunotherapy for recurrent respiratory papillomatosis, potentially marking the first FDA-approved …
Eton Pharmaceuticals announced the ET-900 program, an Investigational New Drug (IND) application for mecasermin in refractory epileptic spasms, leveraging research from Baylor Coll…